Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 65,860,730
  • Shares Outstanding, K 4,078,064
  • Annual Sales, $ 30,328 M
  • Annual Income, $ 4,928 M
  • 60-Month Beta N/A
  • Price/Sales 2.15
  • Price/Cash Flow 8.67
  • Price/Book 4.76
Trade GSK.LN with:
  • Price/Earnings ttm 14.84
  • Earnings Per Share ttm 1.09
  • Most Recent Earnings $0.25 on 05/01/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.58 (3.72%)
  • Most Recent Dividend 0.150 on 05/16/24
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1,588.000 +1.07%
on 06/04/24
1,823.500 -11.98%
on 05/16/24
-179.000 (-10.03%)
since 05/10/24
3-Month
1,575.000 +1.90%
on 04/19/24
1,823.500 -11.98%
on 05/16/24
-80.200 (-4.76%)
since 03/12/24
52-Week
1,302.600 +23.22%
on 07/11/23
1,823.500 -11.98%
on 05/16/24
+231.200 (+16.83%)
since 06/12/23

Most Recent Stories

More News
Stocks Set to Open Higher as Rate Cut Bets Firm, U.S. Jobs Data in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.25%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.37% this morning as speculation over interest rate cuts by major central banks heightened appetite...

ESM24 : 5,440.75 (+0.24%)
NQM24 : 19,637.00 (+0.72%)
CZR : 38.18 (+3.86%)
ZS : 188.83 (+0.63%)
GPS : 26.45 (-1.38%)
MDB : 229.25 (+2.44%)
CRWD : 387.37 (+0.71%)
GTLB : 46.28 (+6.17%)
HPE : 20.91 (+1.70%)
BBWI : 43.70 (-2.24%)
LULU : 309.81 (-2.59%)
DLTR : 108.87 (-0.70%)
Moderna Investors Just Got Some Bullish News

This news could be worth billions...

GSK.LN : 1,605.000 (-0.62%)
PFE : 27.66 (-1.32%)
MRNA : 147.72 (-0.45%)
Is This a Setback for Moderna?

Moderna's shares slipped after the company announced the delay.

PFE : 27.66 (-1.32%)
GSK.LN : 1,605.000 (-0.62%)
MRNA : 147.72 (-0.45%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 12,465.998 (+0.73%)
AZN : 80.07 (+1.06%)
GSK.LN : 1,605.000 (-0.62%)
GSK : 41.11 (+0.12%)
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

These companies are close to launching new products that could supercharge revenue.

LLY : 867.30 (+0.17%)
PFE : 27.66 (-1.32%)
GSK.LN : 1,605.000 (-0.62%)
MRNA : 147.72 (-0.45%)
VRTX : 475.79 (-1.19%)
Babies should get recently approved drug for RSV, CDC says

U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus

PFE : 27.66 (-1.32%)
GSK.LN : 1,605.000 (-0.62%)
GSK : 41.11 (+0.12%)
AZN.LN : 12,465.998 (+0.73%)
AZN : 80.07 (+1.06%)
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,605.000 (-0.62%)
GSK : 41.11 (+0.12%)
BLU.TO : 19.48 (-0.10%)
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results

Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug

SGEN : 228.74 (-0.07%)
AZN : 80.07 (+1.06%)
IMGN : 31.23 (unch)
GSK : 41.11 (+0.12%)
GSK.LN : 1,605.000 (-0.62%)
PFE : 27.66 (-1.32%)
International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment

International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment

FOSUF : 0.5901 (+10.30%)
FOSUY : 14.5300 (+1.25%)
GSK.LN : 1,605.000 (-0.62%)
GSK : 41.11 (+0.12%)
JNJ : 145.41 (-0.92%)
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical...

BLU : 14.74 (unch)
GSK : 41.11 (+0.12%)
GSK.LN : 1,605.000 (-0.62%)
BLU.TO : 19.48 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 1,645.000
2nd Resistance Point 1,633.000
1st Resistance Point 1,619.000
Last Price 1,605.000
1st Support Level 1,593.000
2nd Support Level 1,581.000
3rd Support Level 1,567.000

See More

52-Week High 1,823.500
Fibonacci 61.8% 1,624.516
Last Price 1,605.000
Fibonacci 50% 1,563.050
Fibonacci 38.2% 1,501.584
52-Week Low 1,302.600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar